TECX Projected Dividend Yield
Tectonic Therapeutic Inc ( NASDAQ : TECX )Tectonic Therapeutic, Inc. is a biotechnology company. Co. is focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs). Leveraging its technology platform called GEODe (GPCRs Engineered for Optimal Discovery), the Co. is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. Co.'s lead program, TX000045 (TX45), is an Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone relaxin. 21 YEAR PERFORMANCE RESULTS |
TECX Dividend History Detail TECX Dividend News TECX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |